This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Uncategorised Disease
  • /
  • Upregulation of LAT1 during anti-androgen therapy ...

Upregulation of LAT1 during anti-androgen therapy contribute to progression in prostate cancer cells.

Read time: 1 mins
Published:25th Mar 2020
Author: Xu M, Sakamoto S, Matsushima J, Kimura T, Ueda T, Mizokami A et al.
Ref.:J Urol. 2015 Dec 9. pii: S0022-5347(15)05395-1.

Purpose: Cancer cells require massive amounts of amino acids for survival. L-type amino acid transporter 1 (LAT1) transports essential amino acids, including leucine, which trigger the downstream m-TOR pathway. The association between androgen receptor (AR) and LAT1 and the association between LAT1 expression and acquisition of castration resistance were examined.

Materials and methods: Western blotting and real-time polymerase chain reaction were used to study protein and mRNA expressions. SiRNA was used to knockdown target genes. 92 prostate biopsies specimen of patients who underwent androgen deprivation therapy (ADT) were used for immunohistochemical analyses. Cox hazard proportional models and the Kaplan-Meier method were used for statistical analyses.

Results: LAT1 was highly expressed in hormone-resistant prostate cancer cell lines. Knockdown of LAT1 in LNCaP and C4-2 cells significantly suppressed cell proliferation, migration, and invasion. SiRNA of AR or blocking of AR through bicalutamide (10μΜ) or MDV3100 (10μΜ) significantly increased LAT1 expression (P<0.01). Treatment with DHT (0.1-10 nM) reduced LAT1 expression in a dose-dependent manner (P<0.01). Bicalutamide/MDV3100 plus SiLAT1synergistically suppressed prostate cancer cell proliferation compared to single inhibition of AR or LAT1 (P<0.01). The high LAT1 expression correlated with significantly shorter PSA recurrence free survival in patients receiving ADT (P<0.0001). LAT1 expression (HR 3.56, P = 0.0133) was an independent predictor of castration resistance on multivariate analysis.

Conclusions: The current data may provide a novel mechanism to acquire castration resistance through activation of amino acid transporter LAT1.

Read abstract on library site